TNFRSF9 and gastric cancer: In gastric cancer, the number of tumor‐infiltrating CD8+CD103+ TRM cells is reduced, their cytotoxic function is impaired, and this is negatively correlated with cancer progression and survival. Combining PD‐1 blockade with 4‐1BB costimulation can restore their function.